Back This Medical AI Tech

You don't often find healthcare tech company valued at $4M. HeartSciences is an exception. With $75M invested, including R&D, clinical trials, and product development, their patented AI software is approaching FDA submission, a potential major inflection point.

ABBV
Abbvie Inc
NYSE
189.26
Open 191.51 Prev Close 191.40
High 192.34 Low 188.57
Volume 5,332,142 Volume (Avg) 6,776
52 Week High 214.80 52 Week Low 159.42
Market Cap 334.3B PE Ratio 80.70

Shares Stats

Shares Outstanding1,766,290,000
Shares Float1,764,820,000
Shares Short15,950,000
Insider Holdings10%
Institution Holdings74.40%

About Abbvie Inc

AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, generalized pustular psoriasis, and pyoderma gangrenosum; Skyrizi to treat autoimmune diseases, erythrodermic psoriasis, generalized pustular psoriasis, and palmoplantar pustulosis; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta/Venclyxto to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic to treat neurologic diseases; Vraylar to treat schizophrenia, bipolar disorder, and depressive disorder; Duopa and Duodopa to treat Parkinson's disease; Ubrelvy to treat migraine; and Qulipta for episodic and chronic migraine, as well as other neuroscience products. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; and Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

General

NameAbbvie Inc
TickerABBV
ExchangeNYSE
SectorHealthcare
IndustryDrug Manufacturers - General
CurrencyUSD
CountryUSA
Fiscal Year EndDecember
Full Time Employees55,000

Highlights

Analyst Target214.12
Market Cap334,309,400,000
PE Ratio80.70
PEG Ratio0.41
EBITDA27,366,000,640

Financials

Curr Year EPS Estimate12.24
Next Quarter EPS Estimate3.05
Profit Margin7.24%
Operating Margin30.74
Return on Assets0.08
Return on Equity0.88
Revenue57.4B
Earnings Per Share2.34
Revenue Per Share32.43
Gross Profit40,739,000,320
Quarterly Revenue Growth0.08

Valuation

Trailing PE81.79
Forward PE15.77
Price/Sales (Trailing 12 Mt.)5.89
Price/Book (Most Recent Quarter)238.24

Dividend

Abbvie Inc pays out a dividend of $6.51 per share, with a dividend yield of 3.44%.

ABBV's next dividend payment will be made to shareholders on August 15, 2025.

They pay out 263.15% of their earnings out as a dividend.

Recent Dividends

Aug 15, 2025$1.64
May 15, 2025$1.64
Feb 14, 2025$1.64
Nov 15, 2024$1.55
Aug 15, 2024$1.55
May 15, 2024$1.55
Feb 15, 2024$1.55
Nov 15, 2023$1.48
Most Popular

Trump keeps saying the GOP mega bill will eliminate taxes on Social Security. It does not

WASHINGTON (AP) — President keeps saying that Republicans' mega legislation will eliminate taxes on federal benefits.

Elon Musk Renews Demand for Jeffrey Epstein Files Release, Weeks After Alleging Trump Is Named in Them

Elon Musk has once again demanded the release of the unredacted Jeffrey Epstein files. This comes in the wake of his allegations against President Trump.

Trump's "New Golden Age" Tech to Create $12 Trillion Boom? - Ad

Trump's about to prove everybody wrong. He's been ridiculed for his moves in the trade war... But everything is about to make perfect sense the moment people see Trump's "New Golden Age" tech. Because this little-known technology could ignite a $12 trillion manufacturing revolution... And early investors could see stratospheric gains.

Trump's 'Big, Beautiful Bill' Hands $5 Billion Win To Big Pharma: Report

Trump's $3.3 trillion domestic agenda bill, passed by the House on Thursday, includes a significant victory for pharmaceutical companies .

AstraZeneca In $15 Billion Talks For Drug That Could Upend Lung Cancer Treatment

AstraZeneca is in advanced talks with Summit Therapeutics over a potential $15 billion deal for the lung cancer drug ivonescimab.

FDA Submission Expected This Summer - Invest Before It Happens - Ad

This company is making heart disease easier to detect with AI. Their tech has officially been designated a "Breakthrough" by the FDA. You now have an opportunity to get in at a potential inflection point.

PHOTO ESSAY: In rural Alaska, collecting driftwood saves time, money and brings jobs

GALENA, Alaska (AP) — As ice breaks on the Yukon River, Jake Pogrebinsky looks at the water from shore, searching for a large log floating downstream.

Trump asks Supreme Court to remove 3 Democrats on the Consumer Product Safety Commission

WASHINGTON (AP) — The Trump administration on Wednesday asked the to remove three Democratic members of the , who were fired by President and then reinstated by a federal judge.

Is Elon's Empire Crumbling? - Ad

Jeff Brown - the legend who called Tesla and Nvidia early - says Elon is about to launch a $25T AI revolution. This isn't another chatbot. It's real-world AI that could 14X the impact of ChatGPT. But after July 23rd, it may be too late.

Here's Why 'Altcoin Season' For XRP, ETH, SOL Has Not Happened Yet

Cryptocurrency analyst Benjamin Cowen has argued that an ‘altcoin season‘ has failed to materialize due to monetary policy, liquidity and stubborn Bitcoin (CRYPTO:

Putting Your Name on This List Could Hand You $1,270 on Friday - Ad

URGENT: On Tuesday, a simple set of instructions will be sent out to an elite group of investors. The folks in this group will have the opportunity to place a 10-minute trade that could double their money by Friday. Consider this your invitation to join them. The next trade is just days away.

In a country where alcohol is banned, Pakistan’s top brewery is betting on soft drinks

RAWALPINDI, Pakistan (AP) — A pungent fug of malt and yeastiness hangs over Murree Brewery, ’s biggest and oldest producer of alcoholic drinks.

Samsung unveils its new line of foldable devices at Unpacked

NEW YORK (AP) — Samsung introduced several updates to its foldable devices lineup on Wednesday, with the new Galaxy Z Fold 7, Z Flip 7, and the new Z Flip 7 FE taking stage at the latest Unpacked event.

What's inside Elon's building in Memphis will shock you - Ad

Inside Elon Musk's Memphis site lies a supercomputer built to power the world's first superhuman AI. It could make Elon a trillionaire - and new millionaires, too. With just $500, you could get in before the July 1st funding window closes.

Rescuers search for survivors after Houthi attack on cargo ship in the Red Sea

DUBAI, United Arab Emirates (AP) — Rescuers launched a search Wednesday for survivors of a Liberian-flagged cargo ship that came under attack from in the Red Sea, authorities said. At least three mariners were killed and two were wounded.

Mexican banks face cascading consequences following US sanctions

Mexico City (AP) — Three Mexican financial institutions sanctioned by the Trump administration last week have felt a cascade of economic consequences following the allegations that they helped launder millions of dollars for drug cartels.

Crypto Genius: These 5 Altcoins Could Crush Bitcoin in 2025 - Ad

On August 30th, two powerful "Wealth Drivers" ignite what could be a 2025 super bull run-backed by Trump. The altcoin market as a whole has already soared 132,721% over the past ten years and could surge again. A $900 stake could turn into $108K over 12 months. This is The Great Gain of 2025.

Intel (INTC) Stock Falls On Report Of Major Chip Strategy Shift

Intel shares are trading lower Wednesday afternoon. CEO Lip-Bu Tan is reportedly considering a strategic pivot away from marketing its costly 18A chipmaking process.

Here's how millions of people could lose health insurance if Trump's tax bill becomes law

WASHINGTON (AP) — Roughly 11.8 million adults and children will be at risk for losing health insurance if Republicans' domestic policy package becomes a law.

How to Hack a $1.3T Market - Ad

Forget concrete. The new foundation for real estate success is digital, and Pacaso leads the way. Their tech unlocks a $1.3T real estate market. They've already earned $110M+ in gross profits in their operating history and reserved the Nasdaq ticker PCSO.

House Republicans race toward a final vote on Trump's tax bill, daring critics to oppose

WASHINGTON (AP) — Republican leaders in the House are sprinting toward a Wednesday vote on President Donald Trump's , determined to seize momentum from a in the Senate while essentially daring members to defy their party's leader and vote against it.

ExxonMobil and partner Qatar Energy find new natural gas deposit off Cyprus

NICOSIA, Cyprus (AP) — A consortium made up of ExxonMobil and partner Qatar Energy International has made a second natural gas discovery beneath the seabed south of , the government said Monday, a find that bolsters the region’s potential as an energy exporter.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd.

Amy Coney Barrett Earns Trump's Credit After Court Ruling: 'I Have Great Respect For Her'

Trump praises Justice Barrett's Supreme Court ruling limiting nationwide injunctions, while blasting NYC's Mamdani and defending his economic agenda.

Elon's Greatest Invention... Hidden in South Memphis? - Ad

In South Memphis, I uncovered what could be Elon Musk's biggest invention yet. It's so secretive, rivals are flying drones to spy on it. If you're serious about investing in AI, now's the time to see what's really going on inside those walls.

Iran’s president orders country to suspend cooperation with UN nuclear watchdog IAEA

DUBAI, United Arab Emirates (AP) — Iran’s president on Wednesday ordered the country to suspend its cooperation with after American and Israeli airstrikes hit its most-important nuclear facilities, likely further limiting inspectors' ability to track Tehran's program that had been enriching uranium to near weapons-grade levels.

Back This Medical AI Tech - Ad

You don't often find healthcare tech company valued at $4M. HeartSciences is an exception. With $75M invested, including R&D, clinical trials, and product development, their patented AI software is approaching FDA submission, a potential major inflection point.

Prokidney, Soundhound AI, Quantumscape, Intel, And Nvidia: Why These 5 Stocks Are On Investors' Radars Today

U.S. major indices ended mixed on Tuesday, as the Dow Jones Industrial Average slipped nearly 0.4% to 44,240.76 and the S&P 500 edged down 0.1% to 6,225.52.

Australian airline Qantas says customer data stolen by cybercriminal

Australian airline Qantas said Wednesday that a hacker made off with a trove of customers' personal data including passenger names, emails, phone numbers, birth dates and frequent flyer numbers.

Trump's "New Golden Age" Tech to Create $12 Trillion Boom? - Ad

Trump's about to prove everybody wrong. He's been ridiculed for his moves in the trade war... But everything is about to make perfect sense the moment people see Trump's "New Golden Age" tech. Because this little-known technology could ignite a $12 trillion manufacturing revolution... And early investors could see stratospheric gains.

Senate GOP removes tax on solar and wind energy but dismantles climate law passed by Democrats

WASHINGTON (AP) — The approved by the Senate Tuesday removes a proposed tax on solar and wind energy projects but quickly phases out tax credits for wind, solar and other renewable energy.

650% Later, Rocket Lab CEO Isn't One Bit Worried

Rocket Lab CEO Peter Beck highlights strong demand for launches from both commercial and government customers.

FDA Submission Expected This Summer - Invest Before It Happens - Ad

This company is making heart disease easier to detect with AI. Their tech has officially been designated a "Breakthrough" by the FDA. You now have an opportunity to get in at a potential inflection point.

Carney Faces Cross-Border Pressure Amid High-Stakes US Trade Talks

Carney faces growing criticism at home as Trump threatens steep tariffs amid tense Canada-U.S. trade negotiations.

Faced with geopolitics and trade war, US companies in China report record-low new investment plans

WASHINGTON (AP) — American companies in China are reporting record-low new investment plans for this year and declining confidence in profits, while uncertainty in U.S.-China relations and President Donald Trump’s tariffs have become their top concerns, according to a business survey released Wednesday.

Is Elon's Empire Crumbling? - Ad

Jeff Brown - the legend who called Tesla and Nvidia early - says Elon is about to launch a $25T AI revolution. This isn't another chatbot. It's real-world AI that could 14X the impact of ChatGPT. But after July 23rd, it may be too late.

Donald Trump's Approval Rating Jumps Among Baby Boomers — Here's What's Driving It

President Trump's approval rating among Baby Boomers has seen a significant surge, potentially solidifying his political base as we approach the 2026 midterm elections.

Most Recent

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright trendadvisor.net
Privacy Policy | Terms of Service